Macroencapsulated Human iPSC-Derived Pancreatic Progenitors Protect against STZ-Induced Hyperglycemia in Mice

In type 1 diabetes, a renewable source of human pancreatic β cells, in particular from human induced pluripotent stem cell (hiPSC) origin, would greatly benefit cell therapy. Earlier work showed that pancreatic progenitors differentiated from human embryonic stem cells in vitro can further mature to...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Stem Cell Reports
Autori principali: Haller, Corinne, Piccand, Julie, De Franceschi, Filippo, Ohi, Yuki, Bhoumik, Anindita, Boss, Christophe, De Marchi, Umberto, Jacot, Guillaume, Metairon, Sylviane, Descombes, Patrick, Wiederkehr, Andreas, Palini, Alessio, Bouche, Nicolas, Steiner, Pascal, Kelly, Olivia G., R.-C. Kraus, Marine
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6449839/
https://ncbi.nlm.nih.gov/pubmed/30853374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.stemcr.2019.02.002
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi